Slide Join The Ecosystem. FemTechnology Of Tomorrow. Shaping The Women's Health Solutions Sticky Branding: 12.5 Principles to Stand Out, Attract Customers, and Grow an Incredible Brand - Mosby's Review Questions for the National Board Dental Hygiene Examination Sign Up for the Newsletter

What Do We Do?

FemTechnology Summit

Brings together the most exciting innovators in women’s health for a 360 degree perspective on innovation to solve collective pain-points and catalyze change.  

Contact form 1

    Screenshot 2023-09-05 at 2.28.50 PM

    Sample Contributors:

    Sample Outcomes:

    University Series

    Building the pipeline of innovation in women’s health:

    We scout and connect the next generation of researchers and founders in women’s health at academic institutions to support their work & disseminate their insights to a larger audience.

    Contact form 1

      Contact form 1

        Are you an innovator?

        Work with us: Innovation in women’s health requires an ecosystem approach. 

        We bring together the most cutting-edge players and payers for a 360 degree perspective on innovation in women’s health. 

        Redesigning healthcare so it works for everyone.

        Whether it’s via our Summit, University Series or Guide, we want to build the future with you!

        Contact form 1

          Why do we exist?

          01
          History

          Throughout history women have been considered ‘aberrations’ from the norm, rather than a crucial and vital part of the population to be included in medical trials and long-term studies.

          02
          Participants

          Women of reproductive age were often excluded out of the fear that menstrual cycles and changes in hormones could pose unnecessary complications and act as unpredictable variables.

          03
          Data

          This has resulted in missing data sets and a lack of understanding, diagnosis and treatment of many gynecological conditions that impact large swaths of the female population, as well as unwanted pharmaceutical side effects for non-gynecological diseases, delays in care, underdiagnoses or undertreatment.

          04
          Future

          However – be it by wearables, mobile apps, home testing devices or kits – this is beginning to change, with the emergence of companies beginning to collect large amounts of new data, conduct subsequent research studies and develop new means of treatment.

          Contact form 1